Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses
- T. Krausgruber, K. Blazek, I. Udalova
- BiologyNature Immunology
- 1 March 2011
TLDR
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.
- R. Maini, F. Breedveld, M. Feldmann
- MedicineArthritis and rheumatism
- 1 September 1998
TLDR
Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
- P. Lipsky, D. M. van der Heijde, R. Maini
- MedicineThe New England journal of medicine
- 30 November 2000
TLDR
An inflammatory cytokine signature predicts COVID-19 severity and survival
- D. D. Del Valle, S. Kim-Schulze, S. Gnjatic
- MedicineNature Medicine
- 24 August 2020
TLDR
Role of cytokines in rheumatoid arthritis.
- M. Feldmann, F. Brennan, R. Maini
- Biology, MedicineAnnual review of immunology
- 1996
TLDR
Role of interleukin‐1β in postoperative cognitive dysfunction
- M. Cibelli, A. Fidalgo, M. Maze
- Medicine, PsychologyAnnals of neurology
- 1 September 2010
TLDR
Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis
- M. Elliott, R. N. Maini, J. Woody
- Medicine, BiologyThe Lancet
- 22 October 1994
Tumor necrosis factor-α triggers a cytokine cascade yielding postoperative cognitive decline
- N. Terrando, C. Monaco, D. Ma, B. Foxwell, M. Feldmann, M. Maze
- BiologyProceedings of the National Academy of Sciences
- 1 November 2010
TLDR
Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
- M. Feldmann, R. Maini
- Biology, MedicineAnnual review of immunology
- 2001
TLDR
...
1
2
3
4
5
...